Previous Article | Next Article ![]()
Journal of Virology, December 2001, p. 12161-12168, Vol. 75, No. 24
Department of Immunology, The Scripps
Research Institute, La Jolla, California,1 and
Department of Immunology and Genmab, University Medical
Center Utrecht, Utrecht, The Netherlands2
Received 3 July 2001/Accepted 20 September 2001
The human antibody immunoglobulin G1 (IgG1) b12 neutralizes a broad
range of human immunodeficiency virus-type 1 (HIV-1) isolates in vitro
and is able to protect against viral challenge in animal models.
Neutralization of free virus, which is an antiviral activity of
antibody that generally does not require the antibody Fc fragment, likely plays an important role in the protection observed. The role of
Fc-mediated effector functions, which may reduce infection by inducing
phagocytosis and lysis of virions and infected cells, however, is less
clear. To investigate this role, we constructed a panel of IgG1 b12
mutants with point mutations in the second domain of the antibody heavy
chain constant region (CH2). These mutations, as expected, did not
affect gp120 binding or HIV-1 neutralization. IgG1 b12 mediated strong
antibody-dependent cellular cytotoxicity (ADCC) and
complement-dependent cytotoxicity (CDC) of HIV-1-infected cells, but
these activities were reduced or abrogated for the antibody mutants.
Two mutants were of particular interest. K322A showed a twofold
reduction in Fc
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.12161-12168.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Effector Function Activities of a Panel of Mutants
of a Broadly Neutralizing Antibody against Human Immunodeficiency
Virus Type 1
R binding affinity and ADCC, while C1q binding and
CDC were abolished. A double mutant (L234A, L235A) did not bind either
Fc
R or C1q, and both ADCC and CDC functions were abolished. In this
study, we confirmed that K322 forms part of the C1q binding site in
human IgG1 and plays an important role in the molecular interactions
leading to complement activation. Less expectedly, we demonstrate that the lower hinge region in human IgG1 has a strong modulating effect on
C1q binding and CDC. The b12 mutants K322A and L234A, L235A are useful
tools for dissecting the in vivo roles of ADCC and CDC in the
anti-HIV-1 activity of neutralizing antibodies.
*
Corresponding author. Mailing address: Department of
Immunology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., IMM2, La Jolla, CA 92037. Phone: (858) 784-8602. Fax: (858) 784-8360. E-mail: parren{at}scripps.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|